---
url: https://www.servicesaustralia.gov.au/myelodysplastic-syndrome-lenalidomide
title: Myelodysplastic syndrome - lenalidomide - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:41:18.870Z
source: servicesaustralia.gov.au
---
# Myelodysplastic syndrome - lenalidomide

The PBS subsidises lenalidomide for patients with myelodysplastic syndrome.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with lenalidomide under the _National Health Act 1953_, section 100 for patients with myelodysplastic syndrome.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing lenalidomide.

## Section 100 arrangements

### Lenalidomide

This item is only PBS-subsidised for day non-admitted patients, day admitted patients or patients on discharge who are attending:

-   an approved private hospital
-   a public participating hospital
-   a public hospital.

This item isn’t PBS-subsidised for hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Authority applications

### Applying for initial or first continuing treatment

Patients receiving lenalidomide under this PBS listing must be registered in the i-access risk management program.

Applications for initial or first continuing authority approval to prescribe PBS-subsidised lenalidomide to treat myelodysplastic syndrome can be made either in:

-   real time using the Online PBS Authorities system
-   writing and upload through [HPOS](/hpos?context=20)
-   writing and post to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include the completed:

-   authority prescription form or forms
-   [Myelodysplastic syndrome - initial PBS authority application form](/pb012?context=20)
-   relevant attachments.

### Applying for subsequent continuing treatment

Applications for subsequent continuing authority approval to prescribe PBS-subsidised lenalidomide to treat myelodysplastic syndrome can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs) enquiry line.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
